Our Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS PF) Minimal Disease Activity (MDA), a tool developed at Johns Hopkins and validated within our PsA cohort, allows for exquisite description of the phenotypic features of an individual’s disease at that moment. Our detailed evaluative approach enables us to match optimal, state-of-the-art drug therapy to the specific clinical circumstances of our patients.
In this edition of LEAP Rounds, Dr. Ana-Maria Orbai discusses the art and science of personalized treatment in psoriatic arthritis.
